7. Inviting women to screening programmes
For inviting women to subsequent breast cancer screening rounds, the ECIBC's Guidelines Development Group (GDG):
- recommends using a letter (strong recommendation, moderate certainty of the evidence)
- suggests using a letter with a fixed appointment time (conditional recommendation, moderate certainty of the evidence)
- suggests using a letter with a General Practitioner's (GP) signature (conditional recommendation, high certainty of the evidence)
- suggests using a letter followed by a phone call to remind (conditional recommendation, moderate certainty of the evidence)
- suggests using a letter followed by a written reminder (conditional recommendation, moderate certainty of the evidence)
- suggests not using a letter followed by a face to face intervention (conditional recommendation, low certainty of the evidence)
Inviting women to subsequent screening rounds: letter followed by phone call vs. letter
Issued on: June 2018
Healthcare question
Should a letter followed by a phone call to remind vs. a letter alone be used for inviting women to subsequent breast cancer screening rounds?
Recommendation
The ECIBC's Guidelines Development Group (GDG) suggests using a letter followed by a phone call to remind over a letter alone for inviting women to subsequent breast cancer screening rounds.
Recommendation strength
| Conditional recommendation |
| Moderate certainty of the evidence |
Justification
The GDG made a conditional recommendation for the intervention, based on desirable anticipated effects and equity.
Subgroup considerations
The GDG noted that for the subgroup of women who had a false positive results in the previous screening round the intervention may have moderate costs due to the smaller number of women involved.
Considerations for implementation and policy making
- The comparison evaluated for this recommendation needs to be interpreted in the context of the other comparisons on methods for inviting women to screening programmes evaluated by ECIBC.
- The GDG considered that in certain countries it may not be feasible to implement due to the additional resources required to call women for phone reminders.
- The GDG noted that implementation will have to consider access to cell phones or land lines for women to receive reminder calls and whether laws limiting access to and use of phone numbers for contacting women are applicable in the specific context.
- The recommendation does not cover informed choice, due to a lack of evidence on this important outcome. The GDG suggests that informed choice is an important implementation consideration for this intervention.
Research priorities
- The GDG recommends research on the effect of this intervention on other important outcomes such as informed decision-making.
- Research evaluating the use of electronic messages including e-mail, social media and SMS as compared to paper letters for invitation to screening.
Supporting material
- Organised vs. non-organised screening
- Double vs. single reading in mammograpy screening
- Communication skills training
- Communication with care providers
- Optimal number of mammography readings
- Specialised training
- Risk stratification
- Women aged 40-44: screening vs. no screening
- Women aged 45-49: screening vs. no screening
- Women aged 45-49: annual vs. biennial screening
- Women aged 45-49: annual vs. triennial screening
- Women aged 45-49: triennial vs. biennial screening
- Women aged 50-69: screening vs. no screening
- Women aged 50-69: annual vs. biennial screening
- Women aged 50-69: annual vs. triennial screening
- Women aged 50-69: triennial vs. biennial screening
- Women aged 70-74: screening vs. no screening
- Women aged 70-74: annual vs. biennial screening
- Women aged 70-74: annual vs. triennial screening
- Women aged 70-74: triennial vs. biennial screening
- Single reading with AI support
- Double reading with AI support
- Screening with tomosynthesis vs. mammography
- Screening with tomosynthesis plus mammography vs. mammography alone
- Tailored screening with tomosynthesis
- Screening with tomosynthesis vs. mammography
- Tailored screening with MRI
- Tailored screening with ABUS
- Tailored screening with HHUS
- Informing about benefits and harms: use of decision aids
- Informing about benefits and harms: Numbers in addition to plain language
- Informing about benefits and harms: Infographics in addition to plain language
- Informing about benefits and harms: Story telling in addition to plain language
- Inviting women to screening: letter vs. no invitation
- Inviting socially disadvantaged women to screening: Targeted vs. general communication strategy
- Inviting women with an intellectual disability to screening
- Inviting non-native speakers to screening
- Inviting socially disadvantaged women to screening: Tailored vs. targeted communication strategy
- Inviting socially disadvantaged women to screening: Tailored vs. general communication strategy
- Inviting women to subsequent screening rounds: letter vs. no invitation
- Inviting women to screening: letter with fixed appointment vs. letter
- Inviting women to subsequent screening rounds: letter with fixed appointment vs. lett
- Inviting women to screening: letter with GP signature vs. letter
- Inviting women to subsequent screening rounds: letter with GP signature vs. letter
- Inviting women to screening: letter followed by phone call vs. letter
- Inviting women to subsequent screening rounds: letter followed by phone call vs. letter
- Inviting women to screening: letter followed by phone call vs. no invitation
- Inviting women to screening: letter followed by written reminder vs. letter
- Inviting women to subsequent screening rounds: letter followed by written reminder vs. letter
- Inviting women to screening: letter followed by face to face intervention vs. letter
- Inviting women to subsequent screening rounds: letter followed by face to face intervention vs. letter
- Inviting women to screening: e-mail vs. letter
- Inviting women to screening: automated telephone call vs. letter
- Inviting women to screening: letter followed by automated telephone call vs. letter
- Inviting women to screening: letter followed by SMS notification vs. letter
- Inviting women to screening: letter followed by personalised phone call vs. automated phone call
- Negative result: letter vs. nothing
- Further assessment: letter followed by a phone call
- Further assessment: timing of results
- Negative result: phone call vs. letter
- Negative result: face to face interview vs. letter
- Negative result: timing of results
- Tomosynthesis vs. assessment mammography
- Obtaining a sample from a suspicious breast lesion
- Type of guidance for needle core biopsy
- Stage 1: conventional exams
- Stage 1: PET-CT exams
- Stage 2: conventional exams
- Stage 2: PET-CT exams
- Stage 3: conventional exams
- Stage 3: PET-CT exams
- Stage 3: conventional exams plus PET-CT
- Use of clip-marking
- Additional magnetic resonance imaging
- Contrast-enhanced mammography
- Threshold of oestrogen for endocrine therapy
- Threshold of progesterone for endocrine therapy
- Multigene testing: 70 gene signature at low clinical risk
- Multigene testing: 70 gene signature at high clinical risk
- Multigene testing: 21 gene recurrence score
- Organising screening programmes
- Risk stratification
- Women 40-44
- Women 45-49
- Women 50-69
- Women 70-74
- Women with high breast density
- General Population
- Vulnerable Population
- Informing women about their results
- Women recalled due to suspicious lesions
- Obtaining a sample from a suspicious lesion
- Type of guidance for needle core biopsy
- Stage 1
- Stage 2
- Stage 3
- Planning surgical treatment
- Hormone receptor to guide use of endocrine therapy
- Multigene testing to guide use of chemotherapy